SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-353371
Filing Date
2015-10-26
Accepted
2015-10-26 16:47:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d190486d424b5.htm 424B5 510777
2 GRAPHIC g190486g61r59.jpg GRAPHIC 48366
  Complete submission text file 0001193125-15-353371.txt   578627
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-200452 | Film No.: 151175473
SIC: 2834 Pharmaceutical Preparations